Physician
Urology
Dr. Charles J. Rosser, MD
|
|
Give Review
Dr. Charles J. Rosser is an expert in the field of Urology. He attended Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine Dr. Charles J. Rosser is a published physician. He published 96 publications, including: 'CXCL1 is elevated in the urine of bladder cancer patients.'
Publications
- External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort.
- Urinary Protein Biomarker Panel for the Detection ofRecurrent Bladder Cancer.
- PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation.
- Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.
- Research Highlights: Highlights from the latest articles in biomarkers in medicine.
- Differential Expression Of Stroma Derived Factor-1 Isoforms In Bladder Cancer.
- Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate Cancer.
- Urinary biomarkers of Bladder cancer: an update and future perspectives.
- Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human Cancer xenograft model.
- Attitudes and Knowledge of Primary Care Physicians Regarding Prostate Cancer Screening.
- Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways.
- Multiplex Protein Signature for the Detection of Bladder Cancer in Voided Urine Samples.
- Imaging the urologic patient: the utility of intravenous pyelogram in the CT scan era.
- Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests.
- Complete Genome Sequence of Mycoplasma hyorhinis Strain SK76.
- Diagnostic Potential of Urinary α1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer.
- A multi-analyte assay for the non-invasive detection of Bladder cancer.
- Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis.
- Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for Bladder cancer detection.
- Comprehensive Assessment of Quality of Life and Psychosocial Adjustment in Patients With Renal Tumors Undergoing Open, Laparoscopic and Nephron Sparing Surgery.
- Tumor-associated macrophages mediate immunosuppression in the renal Cancer microenvironment by activating the 15-lipoxygenase-2 pathway.
- Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate Cancer.
- Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification.
- Paper based point-of-care testing disc for multiplex whole cell bacteria analysis.
- Insights into Mycoplasma genitalium metabolism revealed by the structure of MG289, an extracytoplasmic thiamine binding lipoprotein.
- Effects of CXCR4 antagonist CTCE-9908 on Prostate tumor growth.
- Dual targeting of Bcl-2 and VEGF: A potential strategy to improve therapy for prostate Cancer.
- Quality of care for testis Cancer.
- Urine-based assays for the detection of Bladder cancer.
- Bcl-2 mediated modulation of vascularization in prostate Cancer xenografts.
- Structural insights into the extracytoplasmic thiamine-binding lipoprotein p37 of Mycoplasma hyorhinis.
- Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible antiCancer properties.
- Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.
- Persistent exposure to Mycoplasma induces malignant transformation of human Prostate cells.
- Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate Cancer cells in vitro to radiation.
- Delivery of PTEN via a novel gene microcapsule sensitizes prostate Cancer cells to irradiation.
- Knowledge and attitudes of primary care physicians regarding prostate Cancer screening.
- The feasibility of expectant management with inner-city men with newly diagnosed localized prostate Cancer.
- Prostate Cancer knowledge and screening attitudes of inner-city men.
- An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate Cancer.
- Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.
- Outcomes of men who present with Elevated serum PSA (>20 ng/mL) to an inner-city hospital.
- Irradiation of human prostate Cancer cells increases uptake of antisense oligodeoxynucleotide.
- Neoadjuvant therapy and prostate Cancer: what a urologist should know.
- Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human Prostate adenocarcinoma cells.
- Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate Cancer cells.
- Neoadjuvant therapy before radical Prostatectomy: where have we been? Where are we going?
- Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 Prostate tumor xenografts.
- Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the pros...
- Combination of PTEN gene therapy and radiation inhibits the growth of human prostate Cancer xenografts.
- Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate Cancer.
- Impact of fellowship training on pathologic outcomes and complication rates of radical Prostatectomy.
- Biochemical disease-free survival in men younger than 60 years with prostate Cancer treated with radical prostatectomy.
- Prostate Cancer screening and detection in inner-city and underserved men.
- Cystoprostatectomy for effective palliation of symptomatic Bladder invasion by prostate cancer.
- Re: The prostate specific antigen era in the United States is over for prostate Cancer: what happened in the last 20 years?
- Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate Cancer?
- p37 Induces tumor invasiveness.
- Symptomatic local recurrence of Prostate carcinoma after radiation therapy.
- Salvage surgery for bulky local recurrence of prostate Cancer following radical prostatectomy.
- Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate Cancer.
- VURD syndrome managed by pyelostomy.
- Young age is an independent prognostic factor for survival of sporadic Renal cell carcinoma.
- Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure.
- Prognostic value of body mass index in patients undergoing nephrectomy for localized Renal tumors.
- Clinical features and treatment outcome of Hispanic men with prostate Cancer following external beam radiotherapy.
- Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate Cancer.
- Noninvasive detection of Bladder cancer in an orthotopic murine model with green fluorescence protein cytology.
- Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the Prostate.
- Clinical presentation and outcome of high-grade urinary Bladder leiomyosarcoma in adults.
- Bcl-2 is significantly overexpressed in localized radio-recurrent Prostate carcinoma, compared with localized radio-naive Prostate carcinoma.
- Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms.
- Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in Bladder cancer and immortalized human uro...
- Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate Cancer.
- Biochemical disease-free survival in men younger than 60 years with prostate Cancer treated with external beam radiation.
- CXCL1 is elevated in the urine of Bladder cancer patients.
- Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.
- Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion.
- Simultaneous multi-analyte urinary protein assay for Bladder cancer detection.
- Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in Bladder cancer.
- MULTIPLEX URINARY TESTS FOR Bladder CANCER DIAGNOSIS.
- Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive Bladder cancers.
- Conservative surgery and radiation therapy in black women with early stage breast Cancer. Patterns of failure and analysis of outcome.
- Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
- Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.
- Circulating and tumor-infiltrating myeloid cell subsets in patients with Bladder cancer.
- Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in Renal cell carcinoma.
- Exogenous mycoplasmal p37 protein alters gene expression, growth and morphology of prostate Cancer cells.
- Utility of serial urinalyses and Urinary cytology in the evaluation of patients with microscopic haematuria.
- Gene therapy for superficial Bladder cancer.
- Are coagulation studies necessary before percutaneous nephrostomy?
- Is there a learning curve in diagnosing urolithiasis with noncontrast helical computed tomography?
- Thoracoabdominal radical nephrectomy: is a postoperative thoracostomy tube necessary?
- Metastatic small cell carcinoma to the testis.
- Metastatic adenocarcinoma of the pancreas to the testicle: a case report.
Schools
UmdnjRobert Wood Johnson Medical School
North Carolina Baptist Hospital
University Of Texas M D Anderson Cancer Center The
Fairleigh Dickinson Unversity
Procedures Preformed
- AdRenalectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Wake Forest University -
Rutgers Robert Wood Johnson Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Nabil Hilwa, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Vaughan, MD |
|
|
Dr. Troy K. Edwards, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen S. Baker, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey R. Thill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Welch, MD |
|
Dr. George F. Ellis III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert P. Weaver, MD |
|
Dr. Zamip P. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Kata Jr., MD
This Doctor is OpenDoctor Recommended.
|